Regeneron Pharma (REGN) PT Raised to $716 at Credit Suisse
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $793.26 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 34
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 2 | Down: 3 | New: 34
Join SI Premium – FREE
Credit Suisse analyst Evan Seigerman raised the price target on Regeneron Pharma (NASDAQ: REGN) to $716.00 (from $700.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Oracle (ORCL) PT Raised to $250 at UBS Following Q1 Results
- Seven Bank, Ltd. (8410:JP) (SEBNF) PT Raised to JPY270 at JPMorgan
- Adani Ports & Special Economic Zone (ADSEZ:IN) PT Raised to INR2,100 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
